Summary
The Polymerase Chain Reaction (PCR) procedure was applied in order to identify the Newcastle disease virus (NDV), an avian paramyxovirus (A-PMV 1). The sequence selected for amplification consists of 238 bp lying in the gene encoding the fusion protein F. A pair of 19-mer and 18-mer oligonucleotides, flanking this sequence, were used as primers. Following RNA extraction by the proteinase K method, a cDNA was prepared using the previous 19-mer oligonucleotide as the primer. The amplification reaction product was analyzed by electrophoresis and ethidium bromide staining, using the restriction enzymes Hae III, Mbo II, and Nar I. The PCR was performed on cDNA prepared from 30 A-PMV 1 and 3 other strains (A-PMV 2, A-PMV 3, A-PMV 4). It was thereby demonstrated that the selected sequence was highly specific and constant. However, two of the PMV 1 strains isolated from feral ducks, are thought to present a deletion of about 25 bp inside this fragment as shown by the smaller length of the corresponding amplified product and the disappearance of the Nar I restriction site.
The advantages of this technique, as a first step in evaluating virulence by means of molecular biology, is discussed.
Similar content being viewed by others
References
Abenes G, Kida H, Yanagawa R (1986) Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies. Arch Virol 90: 97–110
Alexander DJ, Manvell RJ, Kemp PA, Parsons G, Collins MS, Brockman S, Russel PH, Lister SA (1987) Use of monoclonal antibodies in the characterization of avian paramyxovirus type 1 (Newcastle disease virus) isolates submitted to an international reference laboratory. Avian Pathol 16: 553–565
Alexander DJ (1988) Newcastle disease diagnosis. In: Alexander DJ (ed) Newcastle disease. Kluwer, Boston, pp 147–160
Attree O, Vidaud D, Vidaud M, Anselem S, Lavergne JM, Goossens M (1989) Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genome sequencing of DNA fragments displaying altered melting behaviour. Genomics 4: 266–272
Bingham RW, Chambers P, Emmerson PT (1987) Newcastle disease virus gene clones. European Patent application 0227 414 A2
Erdei J, Erdei J, Bachir K, Kaleta EF, Shortridge KF, Lomniczi B (1987) Newcastle disease vaccine (La Sota) strain specific monoclonal antibody. Arch Virol 96: 265–269
Farr CJ, Saiki RK, Erlich HA, Mc Cormick F, Marshall CJ (1988) Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 85: 1629–1633
Forsey T, Mawn JA, Yates PJ, Bentley ML, Minor PD (1990) Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing. J Gen Virol 71: 987–990
Glickamn RL, Syddall RJ, Lorio RM, Sheehan JP, Bratt MA (1988) Quantitative basic residue requirements in the cleavage activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol 62: 354–356
Jestin A, Foulon T, Blanchard P (1989) Detection of pseudorabies virus DNA in infected cells by in vitro enzymatic amplification. In: Contribution of molecular biology to veterinary virology. Proceedings of the First Congress of the European Society for Veterinary Virology, Liege, 5–7 April, 1989, p 51
Jestin A, Foulon T, Pertuisset B, Blanchard P, Labourdet M (1990) Rapid detection of pseudorabies virus genomic sequences in biological samples from infected pigs using polymerase chain reaction DNA amplification. Vet Microbiol 23: 317–328
Jestin V, Cherbonnel M, Morin M, Guittet M, Bennejean G (1989) Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a panel of monoclonal antibodies to the Ploufragan strain of Newcastle virus. Arch Virol 105: 189–198
Kolakofsky D, Boy de la Tour E, Delius H (1974) Molecular weight determination of Sendai and Newcastle disease virus RNA. J Virol 13: 261–268
Long Le, Brasseur R, Wemers C, Meulemans G, Burny A (1988) Fusion (F) protein gene of Newcastle disease virus: sequence and hydrophobicity. Comparative analysis between virulent and avirulent strains. Virus Genes 1: 333–350
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, New York, pp 230–234
Mc Ginnes LW, Morrison TG (1986) Nucleotide sequence of the gene encoding the Newcastle disease virus fusion protein and comparisons of paramyxovirus fusion protein sequences. Virus Res 5: 343–356
Mc Gookin R (1984) RNA extraction by the proteinase K method. In: Walker JM (ed) Methods in molecular biology, vol 2, nucleic acids. Humana Press, Clifton, NJ, pp 109–112
Meulemans G, Gonze M, Carlier MC, Petit P, Burny A, Le Long (1987) Evaluation of the use of monoclonal antibodies to haemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes. Arch Virol 92: 55–62
Millar NS, Chambers P, Emmerson PT (1988) Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus strain Ulster: molecular basis for variations in pathogenicity between strains. J Gen Virol 69: 613–620
Nagai Y, Klenk HD, Rott R (1976) Proteolytic cleavage of the viral gylcoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 484–508
Nagai Y, Klenk HD (1977) Activation of precursors to both glycoproteins of Newcastle disease virus by proteolytic cleavage. Virology 77: 125–134
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1985) Enzymatic amplification of β-globulin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–1354
Schaper UM, Fuller FJ, Ward MDW, Mehrotra Y, Stone HO, Stripp BR, De Buysscher EV (1988) Nucleotide sequence of the envelope protein genes of a highly virulent neurotropic strain of Newcastle disease virus. Virology 165: 291–295
Toyoda T, Sakaguchi T, Imai K, Inocencio NM, Gotoh B, Hamaguchi M, Nagai Y (1987) Structural comparison of the cleavage activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158: 242–247
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jestin, V., Jestin, A. Detection of Newcastle disease virus RNA in infected allantoic fluids by in vitro enzymatic amplification (PCR). Archives of Virology 118, 151–161 (1991). https://doi.org/10.1007/BF01314026
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01314026